Alberto Osio

Boston, MA (USA)
Role(s):
CEO

Osio Corp.

Location: Boston
Industry: Bio-Technology
Year Founded: 2003
Number Employees: INVALID
Description: Presbyopia, also known as "short arms disease", degrades the eye’s ability to focus on close objects. This occurs at some point in all individuals over the age of forty and is traditionally treated using reading glasses or contact lenses. America’s 77 million Baby Boomers are potential Osio Corp’s patients and present an enormous market opportunity in this country alone. Osio Corp’s patent pending Topical Presbyopia Procedure (TOPP) is the only safe, non-invasive and effective procedure available to treat presbyopes using an ingenious combination of personalized contact lenses, specially formulated eye drops and integrating specification software.